학술논문

Pharmacokinetics, pharmacodynamics, safety, and efficacy of crizanlizumab in patients with sickle cell disease
Document Type
Article
Source
In Blood Advances September 2022
Subject
Clinical Trials and Observations
Language
ISSN
2473-9529